kabutan

JCR Pharma, Returning to Profitability This Year

Tue May 13, 2025 4:00 pm JST Earnings

4552 JCR Pharmaceuticals Co.,Ltd. 【J-GAAP】

Earnings Report

JCR Pharmaceuticals Co.,Ltd. <4552> [TSE Prime] announced its financial results after the market closed on May 13th (16:00). The consolidated ordinary profit/loss for the fiscal year ending March 2025 turned into a loss of 7.47 billion yen (compared to a profit of 7.26 billion yen in the previous period). For the fiscal year ending March 2026, the consolidated ordinary profit/loss is expected to recover to profit of 2.4 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary loss expanded to a loss of 6.09 billion yen (compared to a loss of 0.12 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -3.0% in the same period last year to -82.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 34,343 4,975 5,418 3,772 30.4 20 May 11, 2023 J-GAAP
Mar, 2024 42,871 7,531 7,264 5,507 44.1 20 May 10, 2024 J-GAAP
Mar, 2025 33,072 -6,650 -7,477 -4,759 -38.4 20 May 13, 2025 J-GAAP
YoY -22.9% － － － －

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 33,000 -6,000 -6,700 -4,300 -34.7 20 Mar 27, 2025 J-GAAP
Mar, 2025 Results 33,072 -6,650 -7,477 -4,759 -38.4 20 May 13, 2025 J-GAAP
Revision Rate +0.2% -10.8% -11.6% -10.7% -10.7%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 16,657 -739 -1,621 -691 -5.5 10 Oct 30, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 10 May 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 42,871 7,531 7,264 5,507 44.1 20 May 10, 2024 J-GAAP
Mar, 2025 33,072 -6,650 -7,477 -4,759 -38.4 20 May 13, 2025 J-GAAP
Mar, 2026 Guidance 37,800 2,600 2,400 3,000 24.6 20 May 13, 2025 J-GAAP
YoY +14.3% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 9,153 -278 -124 347 2.8 -3.0 May 10, 2024 J-GAAP
Apr - Jun, 2024 8,145 -296 -257 201 1.6 -3.6 Jul 30, 2024 J-GAAP
Jul - Sep, 2024 8,512 -443 -1,364 -892 -7.1 -5.2 Oct 30, 2024 J-GAAP
Oct - Dec, 2024 9,223 -15 241 115 0.9 -0.2 Jan 31, 2025 J-GAAP
Jan - Mar, 2025 7,192 -5,896 -6,097 -4,183 -33.8 -82.0 May 13, 2025 J-GAAP
YoY -21.4% -2,020.9% -4,816.9% － －

Related Articles